These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23193149)

  • 1. Commentary.
    Ganetsky M
    Clin Chem; 2012 Dec; 58(12):1634-5. PubMed ID: 23193149
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary.
    Milone MC
    Clin Chem; 2012 Dec; 58(12):1635. PubMed ID: 23193150
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescription compliance or illicit designer drug abuse?
    Petrie MS; Lynch KL; Wu AH; Steinhardt AA; Horowitz GL
    Clin Chem; 2012 Dec; 58(12):1631-4. PubMed ID: 23193148
    [No Abstract]   [Full Text] [Related]  

  • 4. Trazodone, meta-chlorophenylpiperazine (an hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine.
    Logan BK; Costantino AG; Rieders EF; Sanders D
    J Anal Toxicol; 2010 Nov; 34(9):587-9. PubMed ID: 21073812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas--liquid chromatographic determination of etoperidone in plasma, serum, and urine.
    Gilmour WJ; Leary JR
    J Chromatogr; 1982 Dec; 233():381-5. PubMed ID: 7161352
    [No Abstract]   [Full Text] [Related]  

  • 6. The trazodone metabolite meta-chlorophenylpiperazine can cause false-positive urine amphetamine immunoassay results.
    Baron JM; Griggs DA; Nixon AL; Long WH; Flood JG
    J Anal Toxicol; 2011 Jul; 35(6):364-8. PubMed ID: 21740694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone.
    Staack RF; Maurer HH
    J Anal Toxicol; 2003; 27(8):560-8. PubMed ID: 14670134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study of the biotransformation of two new drugs, trazodone and etoperidone.
    Melzacka M; Rurak A; Vetulani J
    Pol J Pharmacol Pharm; 1980; 32(4):551-6. PubMed ID: 7255270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amphetamine abuse and drug interactions].
    Horwitz H; Skanning P; Askaa B; Jürgens G
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mephedrone].
    Bertrand X; Gensburger M; Steckx E
    Rev Med Liege; 2011 Oct; 66(10):540-4. PubMed ID: 22141261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous separation of different types of amphetamine and piperazine designer drugs by capillary electrophoresis with a chiral selector.
    Bishop SC; McCord BR; Gratz SR; Loeliger JR; Witkowski MR
    J Forensic Sci; 2005 Mar; 50(2):326-35. PubMed ID: 15813543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer analysis of the pharmacokinetic parameters of EGYT-475, a new antidepressant agent.
    Fehér L; Fonyó M; Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):167-71. PubMed ID: 3432164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of methylenedioxyamphetamine- and piperazine-derived designer drugs in urine by LC-MS/MS using neutral loss and precursor ion scan.
    Montesano C; Sergi M; Moro M; Napoletano S; Romolo FS; Del Carlo M; Compagnone D; Curini R
    J Mass Spectrom; 2013 Jan; 48(1):49-59. PubMed ID: 23303747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid method for the extraction, enantiomeric separation and quantification of amphetamines in hair.
    Strano-Rossi S; Botrè F; Bermejo AM; Tabernero MJ
    Forensic Sci Int; 2009 Dec; 193(1-3):95-100. PubMed ID: 19896309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolism of the antidepressant azaphene in rats].
    Gortinskaia TV; Siniukhin VN; Ostroumova HG; Rozynov BV; Nyrkova VG
    Farmakol Toksikol; 1973; 36(5):673-7. PubMed ID: 4802265
    [No Abstract]   [Full Text] [Related]  

  • 16. The evolving high: new designer drugs of abuse.
    Pourmand A; Armstrong P; Mazer-Amirshahi M; Shokoohi H
    Hum Exp Toxicol; 2014 Oct; 33(10):993-9. PubMed ID: 24501103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.
    Peters FT; Schaefer S; Staack RF; Kraemer T; Maurer HH
    J Mass Spectrom; 2003 Jun; 38(6):659-76. PubMed ID: 12827635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
    Dickson AJ; Vorce SP; Holler JM; Lyons TP
    J Anal Toxicol; 2010 Oct; 34(8):464-9. PubMed ID: 21819791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Absorption and organ distribution of the new antidepressant azaphen].
    Siniukhin VN
    Farmakol Toksikol; 1973; 26(4):409-11. PubMed ID: 4789881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.